Overview

Assess Safety and Efficacy of Vilaprisan in Subjects With Uterine Fibroids

Status:
Completed
Trial end date:
2021-10-25
Target enrollment:
Participant gender:
Summary
The primary objective of this study is to describe the efficacy of vilaprisan in subjects with uterine fibroids compared to ulipristal. The secondary objective of this study is to evaluate the efficacy and safety of different treatment regimens of vilaprisan in subjects with uterine fibroids.
Phase:
Phase 3
Details
Lead Sponsor:
Bayer